Page 17 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A recent Swiss study, despite having a better methodology than previous research, can do little more than fuel hypotheses.

Novo Nordisk and Eli Lilly have pulled ahead in the race for a slice of the weight-loss drugs market, expected to be worth $100 billion by the end of the decade.

A new analysis found that patients with multiple myeloma receiving standard therapies have much worse outcomes compared with those treated in clinical trials.

An exploratory analysis reveals potential associations between a dietary intervention and both a reduction in postmenopausal vasomotor symptoms and changes in the gut microbiome.

Benefits of genetic testing in adults with unexplained epilepsy include enrollment in a clinical trial of a relevant gene therapy, connection to families with a similar diagnosis, and peace of mind.